InsiderClue
Stocks · Health care · Pharmaceutical Preparations

Ultragenyx Pharmaceutical Inc.

RARE Clue Score44
United States Fiscal year ends December CIK 0001515673 Results filed 3 Nov 2026
Add to watchlist

What the insiders did Net selling

Individual transactions

13
Insider
Date
Role
Action
Shares
Price
Amount
Howard Horn
15 Oct 2026
Chief Financial Officer
Sell
7,066
$15.27
$107.90K
Theodore Alan Huizenga
3 Sep 2026
SVP, Chief Accounting Officer
Sell
161
$13.99
$2.25K
Corazon (Corsee) D. Sanders
15 Jun 2026
Director
Sell
2,000
$25.05
$50.10K
Eric Crombez
5 May 2026
EVP and Chief Medical Officer
Sell
344
$24.96
$8.59K
Karah Herdman Parschauer
10 Mar 2026
EVP and Chief Legal Officer
Sell
3,508
$22.67
$79.53K
Karah Herdman Parschauer
6 Mar 2026
EVP and Chief Legal Officer
Sell
6,018
$21.40
$128.79K
Eric Crombez
2 Mar 2026
EVP and Chief Medical Officer
Sell
7,029
$22.80
$160.26K
Theodore Alan Huizenga
2 Mar 2026
SVP, Chief Accounting Officer
Sell
1,632
$22.80
$37.21K
Karah Herdman Parschauer
2 Mar 2026
EVP and Chief Legal Officer
Sell
8,135
$22.80
$185.48K
Emil D Kakkis
2 Mar 2026
President & CEO
Sell
54,404
$22.80
$1.24M
Erik Harris
2 Mar 2026
EVP & Chief Commercial Officer
Sell
10,539
$22.80
$240.29K
John Richard Pinion
2 Mar 2026
See Remarks
Sell
10,029
$22.80
$228.66K
Theodore Alan Huizenga
29 Dec 2025
SVP, Chief Accounting Officer
Sell
85
$34.38
$2.92K
Show all 28 transactions →

What was left out

Form 4 filings counted 40
Amendments (4/A) skipped 0
Filings about a different issuer 0
Unreadable filings 0
Joint filings 0
Sales on a Rule 10b5-1 plan 15
Sales straight out of an exercise 0
Sales at will 13
Transactions with no price 0
Shares from compensation/vesting 459,777
History held since 3 Feb 2014